A Message From The CEO of our Subsidiaries:
OPEN LETTER FROM THE CEO
19 August, 2025
Greetings To All Shareholders, Management, Employees and Customers
I am taking this opportunity to update everyone with the exciting progress that we have made over the past several months regarding the Company’s commitment to its major Distribution Agreement with ThermaBright and the InterceptCS™ and Benepod product lineup.
Our primary focus continues to be the development of our main subsidiary, Global Wellness Products LLC. As you all may know, the core business is the marketing and sale of InterceptCS™, the only proven and approved medical device for the prevention of cold sores, as well as Benepod, a proprietary pain relief device which utilized a hot-cold technology proven to give immediate results.
Once again, relative to the cold sore market and for perspective, the data is as follows:
In the United States and Canada, tens of millions of people experience cold sore outbreaks caused by the Herpes Simplex Virus (HSV-1)
United States
-
-
Prevalence of HSV-1:
According to the CDC, approximately 48% of Americans aged 14–49 are infected with HSV-1 — that’s over 120 million people.
-
-
Cold Sore Occurrence:
Of those infected, 20–40% develop recurring cold sore outbreaks.
-
Estimated 24 to 48 million Americans experience visible cold sores periodically.
-
Canada
-
Prevalence of HSV-1:
Studies estimate that 55–60% of Canadians are infected with HSV-1 — about 20 to 22 million people.
-
Cold Sore Occurrence:
Similar to the U.S., roughly 30–40% will have symptomatic outbreaks.
-
Estimated 6 to 9 million Canadians suffer from cold sores intermittently.
-
Our efforts have been focused upon achieving the various milestones and action items for marketing as outlined previously in our most recent Press Release and Company information. We are very excited to report the following accomplishments as we continue to release our products into the United States and Canada markets:
-
We have resolved the differences between Canada and United States marketing parameters, and InterceptCS™ Thermal Cold Sore Prevention device is now available on Amazon.com (U.S.) and Amazon.ca (Canada).
-
InterceptCS™ is now currently listed and available on Ebay.com, for those shoppers who prefer that particular platform.
-
InterceptCS™ is now available on Tik Tok Shop through our Brand Ambassadors promoting and paid boosting the product through large networks of followers and interested consumers.
-
InterceptCS™ now has its own product page on Facebook, and we will continually post content and boost our postings on that platform.
-
InterceptCS™ has initiated a major SEO and Content Distribution system that will include thousands of content posts to create more visibility over time in search.
-
InterceptCS™ is now being advertised on Google Ads, Twitter Ads, Facebook Ads and several other paid digital platforms for maximum ROI.
Our primary Company product sales website at Intercept-CS.com has been completely redesigned, and the primary website for sale of InterceptCS™ is now complete and fully operational and has already accepted new orders for processing. It has been no small task to put all of this together properly and to achieve the right “look and feel” for maximum results.
We are now moving forward full-speed with our advertising schedule with paid digital advertising and content distribution through all known health related channels. We are looking into the streaming advertising potential as well, an area in which we are very versed and believe will be highly successful once implemented. We are proceeding with attention to detail, analytics and a “slow and steady wins the race” rollout.
R&D continues on our new version of the Thermal Replacement Activator for InterceptCS™. The goal here is to create a multi-use activator that will replace the current single-use activator configuration, and provide greater value to the end-user while creating a greater profit margin for the Company.
We currently have our initial 20,000 units in stock in our fulfillment facility and have already commenced shipping product. This inventory represents our initial milestone goal of $2 Million in gross sales revenue. As we sell through the initial inventory additional production will be initiated on a proper timeline to insure no interruption in fulfillment to our customers. The production of our new redesigned Thermal Activators should commence in the next 30-90 days. Chronic cold sore sufferers run through their initial quantity of 4 Thermal Activators with their device purchase and the consistent reorder potential of replacement Thermal Activators is a significant element of our business plan and future revenue opportunity on a continuing basis.
We will continue to work diligently to place the InterceptCS™ Cold Sore System everywhere it is feasible to maximize our potential for exposure and sale of our primary product.
Our revolutionary new pain relief product Benepod is also now available on several platforms including Ebay and Walmart.com. We will continue to work on additional platforms for sales and we also commenced shipping on Benepod sales and have all confidence in that product to account for another element of our success.
Another exciting update: One our new potential OEM partners has received finalized patent on another new product with tremendous potential that will be added to the Global Wellness Products lineup, and there will be more information on that product in the coming months. We have also been approached by several other OEM firms to potentially sell and distribute their products, and we are reviewing each proposal carefully to make sure we have a proper fit for our infrastructure and overall planning for the growth of Global Wellness Products into a leader in the Health and Wellness space.
It has been a very exciting time here at IMTL and Global Wellness over the past few months. Much has been achieved, and we are now in full product sales launch mode. We appreciate everyone’s patience through this arduous process. We are very proud of our team and all that we have accomplished in such a short time frame. We would also like to give a resounding thank you to our investors and shareholders. We are dedicated to our mission of preventing cold sore outbreaks worldwide, and bringing new and exciting health, wellness and lifestyle products to market.
